Nicotinamide mononucleotide (NMN) improved photoreceptor cell survival by increasing cellular health-promoting and antioxidant enzyme levels.
NMN treatment improves brain associated blood vessel cell survival and protects against harmful stress in metabolic disorders like diabetes.
Research indicates nicotinamide mononucleotide (NMN) supplementation may prevent cognitive impairment in diabetes patients.
Nicotinamide mononucleotide (NMN) intervention protects neurons and memory from diabetes-induced brain degeneration in rats.